KR900701783A - 치환된 6H-피리도[4,3-b]카르바졸 - Google Patents

치환된 6H-피리도[4,3-b]카르바졸

Info

Publication number
KR900701783A
KR900701783A KR1019900700107A KR900700107A KR900701783A KR 900701783 A KR900701783 A KR 900701783A KR 1019900700107 A KR1019900700107 A KR 1019900700107A KR 900700107 A KR900700107 A KR 900700107A KR 900701783 A KR900701783 A KR 900701783A
Authority
KR
South Korea
Prior art keywords
compound
hoocnhr
mammal
composition
schistosomiasis
Prior art date
Application number
KR1019900700107A
Other languages
English (en)
Inventor
아커 시드니
Original Assignee
원본미기재
렌쎌러 폴리테크닉 인스티튜트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 렌쎌러 폴리테크닉 인스티튜트 filed Critical 원본미기재
Publication of KR900701783A publication Critical patent/KR900701783A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용 없음

Description

치환된 -6H-피리도 〔4,3-b〕카르바졸
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 다음의 구조식을 가지는 6H-피리도 〔4,3-b〕카르바졸에서 선택된 화합물과 이들의 제약학적으로 적합한 염:
    이식에서, R는 H, 저급알콕시, OH 및 페녹시에서 선택하고; R'는 H와 CH3에서 선택하고; R″는 CH3와 CR1HOOCNHR2에서 선택하고; R'″는 H와 CR1HOOCNHR2에서 선택하고; R', R″ 및 R'″는 서로 다르며; R'이 CH일때, R는 H가 아닌 다른 것이며; R1은 H와 저급알킬에서 선택하고; 그리고 R2는 저급알킬, 아미노알킬 및 페닐에서 선택한다.
  2. 제1항에 있어서, 사차 암모늄염인 화합물.
  3. 제1항에 있어서, R가 CH30이고, R'이 CH3이고 R″가 CR1HOOCNHR2이고, R'″가 H이고, R1이 H이고 그리고 R2가 CH3인 화합물.
  4. 제1항에 있어서, R가 CH3O이고, R'이 H이고, R″가 CH3이고, R'″가 CR1HOOCNHR2이고, R1이 H이고 그리고 R2가 CH3인 화합물.
  5. 제1항 내지 제4항중 어느 한 항의 화합물의 임상학적 유효량과 제약학적으로 적합한 담체를 포함하는 주혈흡충(schistosomiasis)의 치료용 조성물.
  6. 제1항 내지 제4항중 어느 한항의 화합물의 임상학적 유효량과 제약학적으로 적합한 담체를 포함하는 종양의 치료용 조성물.
  7. 제5항의 조성물을 전술한 주혈흡충을 치료하는데 유효한 양과 섭생으로 전술한 포유동물에 투여하는 것을 포함하는 포유동물의 주혈흡충 치료방법.
  8. 제6항의 조성물을 전술한 종양을 치료하는데 유효한 양과 섭생으로 전술한 포유동물에 투여하는 것을 포함하는 포유동물의 종양의 치료방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900700107A 1988-05-26 1989-05-25 치환된 6H-피리도[4,3-b]카르바졸 KR900701783A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/198,976 US4851417A (en) 1988-05-26 1988-05-26 9-substituted 6H-pyrido[4,3-b]carbazoles
US198,976 1988-05-26
PCT/US1989/002333 WO1989011480A1 (en) 1988-05-26 1989-05-25 SUBSTITUTED 6H-PYRIDO (4,3-b) CARBAZOLES

Publications (1)

Publication Number Publication Date
KR900701783A true KR900701783A (ko) 1990-12-04

Family

ID=22735687

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900700107A KR900701783A (ko) 1988-05-26 1989-05-25 치환된 6H-피리도[4,3-b]카르바졸

Country Status (8)

Country Link
US (1) US4851417A (ko)
EP (1) EP0416024A4 (ko)
JP (1) JPH04501557A (ko)
KR (1) KR900701783A (ko)
AU (1) AU614395B2 (ko)
DK (1) DK278290A (ko)
FI (1) FI905823A0 (ko)
WO (1) WO1989011480A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644451B2 (en) * 1990-06-05 1993-12-09 Toray Industries, Inc. Indole derivative
US5424315A (en) * 1993-08-02 1995-06-13 Sri International Benzothiophen analogs as antiviral agents
FR2757858B1 (fr) * 1996-12-30 1999-01-29 Adir Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69815282T2 (de) 1997-12-25 2004-05-06 Tosoh Corp., Shinnanyo Magnetischer Träger, seine Herstellung, und Verfahren zum Extrahieren von Nukleinsäuren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2152374A1 (en) * 1971-09-09 1973-04-27 Anvar Ellipticin and analogues - by an industrial scale process
FR2248828B1 (ko) * 1973-10-29 1977-04-15 Anvar
US3933827A (en) * 1974-10-29 1976-01-20 Hoffmann-La Roche Inc. 9-Acyloxy-5,11-dimethyl-6H-pyrido[4,3-B]carbazoles
US4310667A (en) * 1976-04-22 1982-01-12 Agence Nationale De Valorisation De La Recherche (Anvar) 2-N Quaternary ammonium salt derivatives of 9-hydroxy ellipticine
FR2485015A1 (fr) * 1980-06-18 1981-12-24 Anvar Derives de l'olivacine et leur application therapeutique
JPS6137799A (ja) * 1984-07-31 1986-02-22 Suntory Ltd エリプチシン誘導体およびその製造法
US4732902A (en) * 1986-05-23 1988-03-22 Hoffmann-La Roche Inc. Pyrroloisoquinolinyl-dimethyloxoalkyl alkonoates and their use as antipsychotic agents

Also Published As

Publication number Publication date
FI905823A0 (fi) 1990-11-26
WO1989011480A1 (en) 1989-11-30
AU3759389A (en) 1989-12-12
DK278290D0 (da) 1990-11-22
DK278290A (da) 1990-11-22
JPH04501557A (ja) 1992-03-19
US4851417A (en) 1989-07-25
EP0416024A4 (en) 1992-04-15
AU614395B2 (en) 1991-08-29
EP0416024A1 (en) 1991-03-13

Similar Documents

Publication Publication Date Title
KR920021556A (ko) 라파 마이신 이량체
KR900011772A (ko) 3-(1,2,5,6-테트라하이드로피리딜)피롤로피리딘
DK282488D0 (da) Farmaceutiske praeparater, deri indgaaende phenylalkylaminger eller salte deraf og forbindelsernes fremstilling
KR900015721A (ko) 신규 방법 및 화합물들
KR890011902A (ko) 디데옥시디데히드로카르보시클릭 뉴클레오시드
KR830009064A (ko) 황함유 화합물이 시클로덱스트린에 내포된 화합물의 제조방법
KR900701264A (ko) 포유류의 파킨슨 증후군 치료법 및 그 조성물
GB2112785B (en) Compositions for treating glaucoma
KR870007190A (ko) 유기백금착물, 이를 사용한 종양 치료방법 및 이를 함유하는 조성물
DE3483798D1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate.
KR900006330A (ko) 피롤로[3,2-e]피라졸로[1,5-a]피리미딘 유도체 및 이를 함유하는 약제
KR900701783A (ko) 치환된 6H-피리도[4,3-b]카르바졸
KR900014397A (ko) 티에노-트리아졸로-디아제핀 술포닐 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR890003368A (ko) 특정의 치환된 페닐알킬아미노(및 아미노산) 유도체 및 기타 세로토닌농도 저하제로 오심 및 구토를 치료하는 방법
ES8507468A1 (es) Procedimiento de obtencion de agentes de beta-bloqueantes conteniendo grupos ester con propiedades oftalmologicas
KR890007741A (ko) 진통제
KR890700584A (ko) 헤테로아릴카르복시아미드 유도체 그의 제조방법 및 그것을 함유하는 의약조성물
ES556336A0 (es) Procedimiento para preparar derivados de esparteina.
KR880013896A (ko) 벤조푸로[3,2-c]퀴놀린 화합물
KR870008885A (ko) 2-알콕시-n(1-아자비사이클로 [2,2,2] 옥트-3-일) 벤즈 아미드-n-옥사이드를 사용하여 구토증을 억제하는 방법
KR920700030A (ko) 진양성 조성물
KR830006229A (ko) 이미다졸 유도체의 제조방법
KR910011820A (ko) Ltb4 합성 저해제
EP0116255A3 (en) Treatment of migraine with n-alkyl-piperidinyl benzoate derivatives
KR960703600A (ko) 활성제로서 이소플라본 유도체 또는 그것의 염을 포함하는 제약학적인 조성물(pharmaceutical compositions containing as active agent isoflavone derivatives or salts thereof)

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid